Table of Contents

2019-2024 Global Ambrisentan Drug Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Ambrisentan Drug Market Size 2014-2024
  • 2.1.2 Ambrisentan Drug Market Size CAGR by Region
• 2.2 Ambrisentan Drug Segment by Type
  • 2.2.1 5 mg Tablet
  • 2.2.2 10 mg Tablet
• 2.3 Ambrisentan Drug Market Size by Type
  • 2.3.1 Global Ambrisentan Drug Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Ambrisentan Drug Market Size Growth Rate by Type (2014-2019)
• 2.4 Ambrisentan Drug Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Drug store
• 2.5 Ambrisentan Drug Market Size by Application
  • 2.5.1 Global Ambrisentan Drug Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Ambrisentan Drug Market Size Growth Rate by Application (2014-2019)

3 Global Ambrisentan Drug by Players

• 3.1 Global Ambrisentan Drug Market Size Market Share by Players
  • 3.1.1 Global Ambrisentan Drug Market Size by Players (2017-2019)
  • 3.1.2 Global Ambrisentan Drug Market Size Market Share by Players (2017-2019)
• 3.2 Global Ambrisentan Drug Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Ambrisentan Drug by Regions

• 4.1 Ambrisentan Drug Market Size by Regions
• 4.2 Americas Ambrisentan Drug Market Size Growth
• 4.3 APAC Ambrisentan Drug Market Size Growth
• 4.4 Europe Ambrisentan Drug Market Size Growth
• 4.5 Middle East & Africa Ambrisentan Drug Market Size Growth

5 Americas

• 5.1 Americas Ambrisentan Drug Market Size by Countries
• 5.2 Americas Ambrisentan Drug Market Size by Type
• 5.3 Americas Ambrisentan Drug Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Ambrisentan Drug Market Size by Countries
• 6.2 APAC Ambrisentan Drug Market Size by Type
• 6.3 APAC Ambrisentan Drug Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Ambrisentan Drug by Countries
• 7.2 Europe Ambrisentan Drug Market Size by Type
• 7.3 Europe Ambrisentan Drug Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Ambrisentan Drug by Countries
• 8.2 Middle East & Africa Ambrisentan Drug Market Size by Type
• 8.3 Middle East & Africa Ambrisentan Drug Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Ambrisentan Drug Market Forecast

• 10.1 Global Ambrisentan Drug Market Size Forecast (2019-2024)
• 10.2 Global Ambrisentan Drug Forecast by Regions
  • 10.2.1 Global Ambrisentan Drug Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Ambrisentan Drug Forecast by Type
• 10.8 Global Ambrisentan Drug Forecast by Application

11 Key Players Analysis

• 11.1 Gilead Sciences
  • 11.1.1 Company Details
  • 11.1.2 Ambrisentan Drug Product Offered
  • 11.1.3 Gilead Sciences Ambrisentan Drug Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Gilead Sciences News
• 11.2 GSK
  • 11.2.1 Company Details
  • 11.2.2 Ambrisentan Drug Product Offered
  • 11.2.3 GSK Ambrisentan Drug Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 GSK News
• 11.3 Hansoh Pharma
  • 11.3.1 Company Details
  • 11.3.2 Ambrisentan Drug Product Offered
  • 11.3.3 Hansoh Pharma Ambrisentan Drug Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 Hansoh Pharma News

...

12 Research Findings and Conclusion

Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension.

According to this study, over the next five years the Ambrisentan Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Ambrisentan Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Ambrisentan Drug market by product type, application, key companies and key regions.

This study considers the Ambrisentan Drug value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
5 mg Tablet
10 mg Tablet
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Drug store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Gilead Sciences
GSK
Hansoh Pharma
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Ambrisentan Drug market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Ambrisentan Drug market by identifying its various subsegments.
Focuses on the key global Ambrisentan Drug players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Ambrisentan Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Ambrisentan Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.